Tammy Chambers is the Director of Health Care Strategy and Advocacy at The Center for Cancer and Blood Disorders, a OneOncology practice with multiple locations across North Texas. With over 30 years of experience in payer relations and managed care contracting, along with a deep understanding of the complexities of cancer treatment, Tammy has successfully navigated the intricacies of payer contracting, value-based care models, and oncology-specific reimbursement strategies. Dedicated to advancing innovation in oncology, she advocates for policies that support cost-effective, patient-centered care. Tammy also serves on the board of the Coalition of Hematology and Oncology Practices (CHOP) as well as the COA Payment Reform Committee.

Emily is a Senior Director of Specialty Product Development within Optum. She is responsible for developing products and services for the Pharmacy Care Services organization that optimize patient outcomes, reduce cost of care, and increase satisfaction of members and providers across the pharmacy and medical benefit.  For nearly 20 years, Emily has been a leader within Optum and the health care industry working to bring programs to market across core focus areas of population health management, customer service, benefit transparency, and provider networks.

Emily is an active participant in The Women's Health Leadership TRUST (WHLTrust) organization that supports leaders in health care.  She is native to the Midwest and currently lives in St. Paul with her family.

Kiana Mehring, MBA, is Vice President of Payer Strategy & Revenue Cycle Management at Florida Cancer Specialists & Research Institute. With deep expertise in managed care and strategic partnerships, she leads initiatives that foster collaboration between payers and providers to advance value-based oncology care. Kiana is recognized for designing innovative payment models and implementing holistic care strategies that enhance patient outcomes while optimizing cost-efficiency. Her leadership reflects a commitment to sustainable, patient-centric solutions in an evolving healthcare landscape.

Dr. Patel is a practicing medical oncologist, board certified in Hematology, Oncology, and Internal Medicine.         

He is immediate past president for the Community Oncology Alliance (COA), He is past for the clinical affairs and trustee for the Association of Community Cancer Centers (ACCC). He has published/presented over 120 papers. He is frequently interviewed and cited in mainstream newspapers including NY times, Washington Post, NPR just to name a few including on key issues like Covid 19, Healthcare disparities (CHD), value-based care. He is also frequently invited by WH team to opine of Cancer Moonshot program. He has been an advisor for the large payers including DHHS (SC), Palmetto GBA, and serves on an advisory board for Medicaid HMOs. He has a special interest in health care policy and economics. He has authored a book on the end of life care published by the Penguin Random House. www.betweenlifeanddeath.org

Additionally, Dr Patel has been working directly with cancer patients for the last twenty years as a community oncologist. He has served as chairman of several committees in numerous South Carolina hospitals. Dr. Patel has extensive legislative experience both at the local and national level and has state senate as well as has carried out capitol hill briefing.

He has been honored by the US Congress for his exceptional contribution to healthcare. Multiple journals have written about his life. He is now working with multiple national entities on CHD. He has started a foundation no one left alone www.nooneleftalone.org to address cancer health disparities. Other organization he has founded and is actively involved in running them include www.ccorn.net, www.cbcca.net, www.kashyappatel.com. 

Dr. Latha Raja Shankar joined Blue Cross and Blue Shield of New Mexico (BCBSNM) as chief medical officer (CMO) in 2022.  As Vice President and Chief medical officer, Dr. Shankar is responsible for the development and clinical oversight of BCBSNM’s health care management programs. In addition, Dr. Shankar is responsible for overseeing provider relations and maintains effective relationships with physicians, hospitals and medical service companies.

Dr. Shankar has served as a physician executive for over a decade and is experienced in ambulatory, inpatient and managed care settings.  She has served in chief medical officer roles in Molina health care and Centene corporation’s subsidiary in New Mexico. 

Dr. Shankar has a medical degree from Madras Medical College in Chennai, India and holds a Master of Business Administration from the University of Tennessee, Knoxville. She has authored and co-authored various published articles on medical research and clinical and patient experience. Dr. Shankar currently serves on the board of the New Mexico Chapter of the American Heart Association and sat on the board of directors for many non-profit organizations including National alliance on mental illness of New Mexico, New Mexico Telehealth Alliance board and Doña Ana Wellness Institute advisory council. 

Dr. Shankar’s interests include reading, writing, speaking, practicing meditation for mindfulness, mentorship, travelling, and nature walking her three dogs Mickey, Milton and Mac. 

Robert has extensive experience in healthcare management, developing strategic plans and directing financial, operational, and clinical initiatives.  He is currently the President of the National Cancer Treatment Alliance (NCTA) a national network of community oncology practices whose focus is to contract directly through value-based agreements with health care purchasers for oncology services.  Prior to joining NCTA Robert was the CEO of Dayton Physicians, where he merged 3 independent Physician practices (Medical Oncology/Radiation Oncology/Urology) to create a large multi-specialty practice.  

Robert received his Bachelor of Science in Education from Bowling Green State University, Master of Science in Hospital and Health Service Administration from Central Michigan University, and a Nursing Degree from Excelsior College.

Robert is married with three children and enjoys travelling, hiking, and spending time with family and friends. 

Marianne Fazen, PhD is Executive Director of DFW Business Group on Health (DFWBGH), a coalition of 50 North Texas employers committed to improving healthcare quality, access and affordability for employees.  Ms. Fazen also serves as President and CEO of the Texas Business Group on Health, a non-profit statewide association advocating Texas employers’ interests in state and federal healthcare policy issues. 

As part of her leadership role in DFWBGH and TBGH, Ms. Fazen also serves as Regional Director of the national Path Forward for Mental Health & Substance Use initiative, and Regional Director of the Leapfrog Group in North Texas. 

Ms. Fazen is a frequent speaker and commentator on employer-related healthcare issues.  She also is recognized as one of Dallas 500 Most Powerful Business Leaders by D CEO Magazine for seven years and as a DFW Healthcare Leader by Dallas Business Journal.

Ms. Fazen currently serves on the Board of Governors of National Alliance of Healthcare Purchaser Coalitions and previously on the Board of Directors of URAC, a national healthcare accreditation agency, including a term as Board Chair.  She also serves as an Officer on the Board of Directors of Equest, Inc., a non-profit equine therapy organization based in Dallas.

Prior to her role as DFWBGH Executive Director, Ms. Fazen was Manager of Marketing & Managed Care Research at VHA Hospital System.  She also was an Adjunct Professor at University of Dallas Graduate School of Management teaching healthcare management strategies and published a book on managed care terminology, entitled Managed Care Desk Reference, to familiarize business leaders and healthcare professionals with the managed care industry.

Ms. Fazen has an undergraduate degree in Medical Technology from the University of Wisconsin and a Doctorate in Communications Science & Human Development from the University of Texas at Dallas.

Terri has more than 30 years’ experience in the health and welfare consulting industry.
She has extensive experience working with healthcare providers in managing employee
benefits programs and understands the nuances associated with providing benefits
as both the payer and provider of care. She currently oversees strategic and tactical
consulting on the design, management and analysis of employee benefits and industryspecific
benchmarking and trends. Terri’s experience and industry-specific knowledge
allow healthcare clients to align their benefit strategies with organizational initiatives,
whether clinical, work force engagement, recruitment or retention with innovative
solutions.

Dr. McAneny is a board‐certified medical oncologist/hematologist based in Albuquerque, New Mexico and
the co‐founder and CEO of New Mexico Oncology Hematology Consultants. She was the 173rd president
of the American Medical Association and used that position to encourage the AMA to file its successful
lawsuits blocking the consolidation of large insurance companies and protecting Title 10 funding. Prior to
her Presidency, Dr McAneny served for 10 years on the AMA Board of Trustees, including as Chair. As the
Delegate from ASCO, prior to her election to the Board, she served 8 years and chaired the AMA policy
committee, the Council on Medical Service. Dr. McAneny is a fellow and former member of the ASCO
Board of Directors, a past president of the New Mexico Medical Society (NMMS), the Greater
Albuquerque Medical Association and the New Mexico Society of Clinical Oncology. In 2012, Dr McAneny
received a $19.8 M award from CMMI to create COME HOME, Community Oncology Medical Home, which
was the precursor to the Oncology Care Model and many other value‐based care processes for oncology.
Dr. McAneny is the co‐chair of the board and one of the Founders of the ONCare Alliance, a network of
independent oncology practices across the United States, organized to provide collaborative, cutting‐edge
oncology care, to bring clinical trials to community practices, to develop new alternative payment models
based on sound data‐driven principles and teach young and mid‐career oncologists how to manage a
successful practice. Prior to this, she was a founding member of Oncology Circle, a group of oncology
practices using data to promote best practices and contribute data to ASCO’s Practice Net. As an early
advocate of managing the social determinants of health, she founded New Mexico Cancer Center
Foundation which helps cancer patients overcome barriers to care by providing grants to pay for their
non‐medical expenses. Now she is developing the Cancer Safety Net Foundation to help ONCare Alliance
practices address patients with their non‐medical needs so patients can focus on getting their care.
Currently she is President of New Mexico Independent Doctors, a clinically integrated network of practices
committed to improving care in New Mexico.

Kelly is an engaging, entertaining speaker with an educational approach to help attendees understand pertinent foundation, current trends, and outlook within a context of how to pragmatically apply learnings to advance their work and improve the outlook of health and benefits. She develops academic, research-based content combined with an entertaining, story-telling delivery that engages and involves an audience and leaves them empowered to action.

Kelly brings fourteen years of experience in wellness, population health, and quality improvement. She currently leads Brown & Brown’s National Mid-market Population Health Consultant Team.

She is a former board member of the Worksite Wellness Council of Massachusetts where she also served as the Programs Committee Chair. In her previous roles with Gallagher and Fred C. Church, she worked with employers of all sizes and industries to improve health outcomes and increase engagement.
 

She is a Certified Wellness Program Manager through the Chapman Institute and is Certified in Public health (CPH). She earned her Master of Public Health from the University at Albany and her Bachelor’s degree in Biochemistry from Elizabethtown College. She has served as an examiner for Partners in Performance Excellence, using the Malcolm Baldridge excellence principles to strategically evaluate organizations.
 

She resides in Central Massachusetts with her husband and two children. She is a certified indoor cycling instructor and enjoys competing in sprint distance triathlons in her spare time.

Sherri Samuels-Fuerst is the former VP – Total Rewards at Sargento Foods Inc. She holds a Bachelors of Science in Nursing and a Masters in Industrial and Labor Relations from the University of Wisconsin - Milwaukee.  She is a Registered Nurse and a Certified Employee Benefits Specialist through the International Foundation of Employee Benefits, as well as a Professional in Human Resources through SHRM. Sherri served as the Chair of the MBGH Board of Directors for 2 years and currently serves as an Ex-Officio. She shares her passion for employee health and wellbeing whenever she can through her work with many local community committees and coalitions and is a frequent national presenter on the topic. 

Alexandra Chong, PhD, is an analyst for CMS Innovation Center.  Alexandra is currently Deputy Director of the Division of Ambulatory Payment Models, which oversees the oncology model development at the CMS Innovation Center.  She has previously served as the policy lead for the Enhancing Oncology Model (EOM) and Oncology Care Model (OCM) and has been at CMMI since 2016.  Alexandra has extensive experience and expertise in experimental design and theories in social-health psychology, the development and implementation of value-based care in oncology and its relation to Medicare payment reform. 

Ted Okon is a nationally recognized expert on the policy and politics of cancer care. He is quoted extensively in the press, including guest appearances on TV and radio news shows. Ted has testified before Congress on cancer issues and is frequently on Capitol Hill discussing the nation’s cancer care delivery system. Ted’s target areas of expertise include the cost of cancer treatment, health care reform, Medicare reimbursement, pharmacy benefit managers (PBMs), drug shortages, and the changing landscape of cancer care delivery in the United States.

Ted has dedicated his career to healthcare business and policy. He has worked for several pharmaceutical companies including Merck and Warner-Lambert, now part of Pfizer, and IMS Health. He co-founded and took public the health care information business Medical Marketing Group. He also founded two oncology companies (an oncology clinical research network and an information network) and has traveled extensively to China, India, Singapore, the U.K., and the Middle East, analyzing and discussing cancer care delivery.

As executive director of the Community Oncology Alliance (COA), Ted oversees the strategic direction of this non-profit organization dedicated to patients and providers in the community cancer care setting, under the direction of a dedicated board of oncologists and practice administrators. Ted also travels the country speaking to state oncology societies, professional organizations, and companies about the challenges facing the nation’s cancer care delivery system. He has authored numerous articles and studies relating to cancer care policy and politics, reimbursement, and clinical issues.

Ted holds a BS degree from Fairfield University and an MBA from the Carnegie-Mellon University Tepper School of Business. His wife Susan practiced as a certified oncology nurse.

Nicolas Ferreyros is Managing Director of Policy, Advocacy, and Communications at the Community Oncology Alliance (COA), the only national organization dedicated solely to preserving and protecting local, affordable, and accessible cancer care. He is responsible for all internal and external communications at COA, including media relations, policy communications, and digital strategy.

A seasoned advocacy and communications strategist with more than 15 years of experience in health care, Nick specializes in developing successful campaigns to address complex issues. He has a deep understanding of the people and processes that affect America’s health care system and has a knack for translating the “wonkery” of health policy into language and concepts that resonate with policymakers, providers, patients, and voters.

Nick has engaged in nearly every major recent health policy issue before Congress and regulatory agencies, including the Affordable Care Act, the 340B Drug Pricing Program, Medicare reimbursement policy, and more. He has worked closely with policymakers on Capitol Hill, the White House, the Department of Health & Human Services, Food and Drug Administration, and National Institutes of Health. Nick’s work has appeared in The New York Times, The Washington Post, The Wall Street Journal, USA Today, CBS Evening News, National Public Radio, and other leading national news outlets.

Prior to joining COA, Nick was a Managing Supervisor at GYMR Public Relations, a boutique Washington, DC communications firm specializing in health care, science, and social issues. While there, he oversaw high-profile, award-winning campaigns for clients including the Robert Wood Johnson Foundation, American Board of Internal Medicine, Consumer Reports, and numerous federal agencies.

A native of Houston, Texas, Nick earned a bachelor’s degree in political science from McGill University in Montreal, Canada. He currently resides in New York City.

Mark Newsom provides policy analysis and strategic advice to stakeholders across the healthcare continuum, with a focus on government health programs. Before joining Avalere, Mark served as deputy director of the Medicare Drug Benefit and C&D Data Group (MDBG) at the Centers for Medicare & Medicaid Services (CMS). MDBG drives Medicare Part D benefit policy and formulary reviews and the Stars quality program for both Medicare Advantage (MA). Previously, Mark held leadership and policy positions in the Medicare Plan Payment, Medicare Advantage and Hospital and Ambulatory Policy Groups at CMS. Mark has also served as an advisor at the Congressional Research Service (CRS) during the development of the Affordable Care Act. On the corporate side, Mark has held senior policy and compliance roles at Humana, CVS Health and Coventry. Mark holds an MS in health policy and administration from the University of Illinois and completed the business of healthcare program at Johns Hopkins University.

Alexandra Zaleta, PhD, is Associate Vice President of Research and Insights at CancerCare, a national non-profit providing free support to people affected by cancer. As a research scientist, clinical psychologist, and caregiver advocate, Dr. Zaleta leads person-centered research on access, affordability, and the real-world impact of insurance barriers on people with cancer. She is a nationally recognized expert in patient and caregiver experience and is committed to translating research insights into policy and programmatic action. Dr. Zaleta completed her PhD in Psychology at Washington University in St. Louis, clinical internship at the VA Boston Healthcare System, and postdoctoral training at Ohio State Wexner Medical Center. She also holds degrees from Harvard University (EdM) and Vassar College (BA).

Dr. Katherine Baker is a practicing medical oncologist and Medical Director of Value-Based Care at Tennessee Oncology. In this role, she leads some of the many care innovation efforts of the practice to provide high quality, patient-centered care. As a Georgia native, she received her undergraduate degree at the University of Georgia and her medical doctorate at the Medical College of Georgia at Augusta University. She completed her internship and residency training in Internal Medicine at Brigham and Women’s Hospital in Boston, Massachusetts. In June 2024, she completed fellowship training at Vanderbilt University Medical Center, during which time she served as chief fellow for two consecutive years. She also received a Master of Management in Healthcare from the Vanderbilt Owen Graduate School of Management.  In addition to her role at Tennessee Oncology, Dr. Baker is an active board member of the Tennessee Oncology Practice Society and the Community Oncology Alliance Fellows Board.

Dr. Sibel Blau is a Hematologist and Oncologist with special interest and expertise in breast cancer, multiple myeloma, and cell therapy.

She is the President/Executive Chair of the board at Northwest Medical Specialties, PLLC, where she also runs the clinical research and Precision Medicine program.  

She is one of the founding members and the President/CEO and Co-Chair of ONCare Alliance, LLC that is a national organization with a focus of value-based care, education, and research, as well as Exigent Research, an innovative research network of independent practices throughout the US to provide high quality, accelerated and accessible research to the communities where patients are treated.  Quality Cancer Care Alliance Network (QCCA) and National Cancer Care Alliance (NCCA) merged to form ONCare Alliance. She is a board member and the current President of Washington State Medical Oncology Society (WSMOS). She is involved in multiple committees at national organizations like ASCO, COA, ACCC.

She is also a member of All4cure, which provides a transparent platform for oncologists with comprehensive displays of their patients’ data, cutting-edge analytic tools, and a real-time learning environment to empower the delivery of expert level myeloma care via clinical pathways that open a door to cooperative learning and new paradigms for curing myeloma.

She is the founder and president of the Journey Fund which is a community-based, not-for-profit organization committed to cancer patients facing barriers that affect their treatment with donations and community resources that make it possible for us to assist cancer patients facing social, financial, or emotional obstacles, toward a courageous journey, with dignity.

Dr. Indurlal has more than a decade of experience in oncology healthcare management and value-based care, leading initiatives that bridge clinical excellence with cost-effective outcomes. Most recently, he served as the senior director of care transformation and analytics at The US Oncology Network, where he led the adoption and implementation of value-based care programs across the network. Prior to that, he was the director of clinical services and operations for Illinois Cancer Specialists, a large medical/radiation oncology practice in the Chicago region. He is experienced in medical management, healthcare strategy, operational execution, financial management, utilization management, care redesign and transformation, practice growth, healthcare quality, alternative payment models, payer relationships, and data and analytics. His research on oncology value-based care and care transformation has been presented at national conferences such as ASCO and NCCN. He has published articles in JCO, JAPhA and JNCCN, and has presented at national and industry conferences on value-based care, provider strategy, practice management, and care transformation.

Dr. Rich Ingram is a highly accomplished oncologist with over two decades of experience in advancing cancer care through compassionate patient advocacy, clinical excellence, and collaborative leadership. As an influential figure in community oncology, he has made substantial contributions at the local, state, and national levels, continually striving to improve the quality and accessibility of cancer care.

Dr. Ingram currently serves as the Payor and Care Transformation Co-Medical Director within the US Oncology Network, where he co-leads the Value-Based Care Program. In this role, he focuses on developing and implementing strategies that integrate clinical excellence with value-based care models to enhance patient outcomes and optimize care affordability. His expertise in aligning healthcare delivery with innovative care models positions him as a thought leader in the transformation of oncology practice.

In addition to his role with the US Oncology Network, Dr. Ingram is the President of the Virginia Association of Hematologists and Oncologists, the Co-founder and Chair of the Appalachian Community Cancer Alliance, and serves on the Board of Directors of the Community Oncology Alliance. In these roles, he leads initiatives that expand access to high-quality cancer care, particularly in underserved regions. His leadership has been instrumental in growing advocacy efforts and strengthening community partnerships that drive meaningful change in cancer care delivery.

At Shenandoah Oncology Associates in Winchester, VA, Dr. Ingram has served as practice president and continues to be the value-based care physician champion. In these roles, he has guided the practice in delivering comprehensive, patient-centered care while integrating innovative care models to enhance patient outcomes and optimize treatment efficiency.

Outside of his professional endeavors, Rich enjoys spending quality time with his family, exploring the vibrant arts and culture scene in his community, traveling to new destinations, and discovering culinary delights from around the world with his friends and family.

Dr. Wilfong is Senior Vice President of Value-Based Care at Thyme Care, the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. He is also a practicing medical oncologist/hematologist, at Texas Oncology in Dallas, Texas. Prior to his role at Thyme Care, he served as Senior Vice President of Payer and Care Transformation at The US Oncology Network and as Vice President of Value-Based Care and Quality programs at Texas Oncology.   

A committed advocate for community oncology, Dr. Wilfong’s mission is to transform cancer care to deliver better outcomes by aligning patient goals and values with treatment options and payment models. In his role at Thyme Care, he is helping define the future of value-based care payment reform, improving care-team coordination, optimizing actionable analytics and improving the quality of patient care. 

While at The US Oncology Network, Dr. Wilfong was instrumental in implementing both the Oncology Care Model and the Enhancing Oncology Model while driving performance in multiple commercial value-based care contracts. He previously led the Value-Based Physician Champion task force for The US Oncology Network and chaired the US Oncology Pathways Task Force. Dr. Wilfong currently co-chairs the Community Oncology Alliance Payer Reform Committee and serves on the ASCO drug shortages committee. He formerly volunteered on the ASCO quality measures task force and the ASCO guidelines committee.  While at Texas Oncology, Dr. Wilfong served as medical director of the COVID-19 Task Force and was the physician lead for their electronic medical record conversion. He has received various teaching and community service awards and has published over 50 papers and abstracts.

In 2003, Dr. Wilfong completed a fellowship at the University of Texas Southwestern Medical School in Dallas in hematology and medical oncology. He completed his internship and residency in internal medicine at the same school in 2000, as well as earned his M.D. from there in 1997. He earned a B.S. degree in mathematics at Texas Tech University in Lubbock, Texas, in 1993.

Dr. Annette C. Fontaine is a native of the Caribbean Island of Dominica. She received her medical training at Ross University School of Medicine on the island and then migrated to the United States. She did residency in Internal Medicine followed by a fellowship in Hematology/Oncology at West Virginia University in Morgantown, West Virginia. In 2006, she joined New Mexico Hematology Oncology Consultants, Ltd. where she cares for patients with solid tumors and hematologic malignancies. Her interest in the business of medicine led her to earn an MBA from the University of Tennessee, subsequently accepting the role of Chief Medical Officer at the cancer center. 

She is passionate about making a difference in the lives of patients and her peers hence she volunteers her time on the board of trustees of the Greater Albuquerque Medical Association, Councilor of New Mexico Medical Society, President of New Mexico Society of Clinical Oncology and Medical Director of Dominica Health and Education Initiative.

She is board certified in Hematology and Medical Oncology and a member of AMA, ASCO and ASH. 

As CEO of Highlands of Oncology in NW Arkansas, Jeff Hunnicutt has demonstrated a passion for creating a work environment where people are engaged and energized to provide outstanding patient care. Specializing in comparative analytics in oncology, Jeff has helped drive the success of his practice by providing an in-depth look into the underlying data that helps give direction to operational decisions. Jeff has been distinguished for his efforts by participating on the Board of Trustees and being recognized as a service fellow for ACCC, serving as ACS Chair in NW Arkansas, serving as a board member with the COA Administrator Network as well as in his previous role as Executive Director of the Quality Cancer Care Alliance (QCCA). Jeff also serves on the Red River Region for the Leukemia and Lymphoma Society and as the chair for Oncology Supportive Services in NW Arkansas.

In his personal life, Jeff is married with 4 children, living in Bentonville, AR. He and his family are deeply involved in projects to bring quality education to the remote areas of Senegal, Africa, and toward raising awareness for the foster system in their state. 

Dr. Debra Patt is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer and research in healthcare informatics driving digital healthcare tool adoption in clinical practice to improve the patient journey.

She is the managing partner for the central Texas, Gulf, and Rio Grande Valley regions in Texas Oncology since 2023.

Dr. Patt is the medical director for public policy for The US Oncology Network and has testified before the US Congress and Senate to protect access to care for cancer patients. She has chaired the council on legislation and the cancer committee for the Texas Medical Association.

Dr. Patt serves as the current vice president of the Community Oncology Alliance and on the ASCO Board of Directors. She also chairs the Artificial Intelligence Task Force for ASCO and is the liaison for the clinical innovation committee.

She lectures medical students and is a professor at Dell Medical School at The University of Texas at Austin.

Susan is the vice president of clinical innovation at AON and oversees the clinical programming function that includes care plan design, care program implementation and monitoring, and clinical integration with payers and providers.

She has over 25 years of experience in healthcare. Previously, she was the executive director of clinical strategy at Oncology Consultants in Houston, Texas, where she developed and implemented innovative clinical strategies and policies that led to the growth of the company. Susan has created clinical and operations protocols for all levels of practice to promote value-based care initiatives in both commercial and non-commercial payer populations. She has established an appropriate framework and oversight, including input into growth, strategy, resourcing, and decision-making to innovate around consumer-focused oncology programs. Developing a community-based oncology navigation program and collaborating to implement a fully integrated initiative to address social determinants of health within the practice has been significant in her role.

Susan currently sits on the COA Administrators Network Board (CAN), the COA Patient Advocacy Network (CPAN) Advisory Panel and the Houston Cancer Health Equity Collaborative. She is an advisor to the Health Equity & Access Committee for the Texas Society of Clinical Oncology (TxSCO) and sits on the COA Health Equity Committee.  

Susan holds a Bachelor of Science in Nursing from the University of Pittsburgh and a Master of Science in Nursing Administration from the University of Texas at Arlington. Additionally, she has the Nurse Executive Advanced Certification and has held the Oncology Nurse Certification for 16 years.